factual

Subcutaneous second generation improves patient experience

Argenx's first-generation drug was intravenous, requiring a roughly one-hour hospital infusion, while the second-generation subcutaneous injection changes the treatment experience for patients.

factualpending

Speaker

Julia

Evidence Quote

“the second generation of the drug is subcutaneous. So it's an injection in a muscle, which completely changes the experience of the treatment.”

Source

Argenx: Changing Lives with Llamas— Business Breakdowns
Created: 11/17/2026, 3:39:21 AM

Your notes

Loading notes...